Rita Sanghvi Mehta, MD, UC Irvine Health, talks about Cyclin-Dependent Kinases to Endocrine Therapy | Adding CDK-46 inhibitors to Frontline or 2nd-Line Setting at MOASC 2018.
Cyclin-Dependent Kinases to Endocrine Therapy | Adding CDK46 inhibitors to Frontline or 2nd-Line Setting
